newsfilter
← Latest News
GlobeNewswire·

Landos Biopharma to Participate in Truist Securities CEO Fireside Chat Series (Virtual)

BLACKSBURG, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ:LABP), a late-clinical-stage biopharmaceutical company utilizing its LANCE® advanced A.I. platform to develop novel therapeutics for patients with autoimmune diseases,